HIGHLIGHTS
- who: Rachel Kerslake and colleagues from the Division of Biosciences, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge , PH, UK have published the research: Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer, in the Journal: (JOURNAL) of 20/06/2022
- what: The authors investigate changes at transcriptomic level (using RNAseq), in human OvCa cells treated with asprosin in_vitro. The authors aim to further elucidate the signalling pathways associated with asprosin using functional enrichment analyses of identified differentially regulated genes (DEGs) and explore its role within the tumour microenvironment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.